The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia

Autor: Antonio Gallo, Leopoldo Pérez de Isla, Sybil Charrière, Alexandre Vimont, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José L. Díaz-Díaz, Daniel Zambón, Philippe Moulin, Eric Bruckert, Pedro Mata, Sophie Béliard, Denis Angoulvant, Sophie Beliard, Franck Boccara, Bertrand Cariou, Valérie Carreau, Alain Carrie, Sybil Charrieres, Yves Cottin, Mathilde Di Filippo, Pierre Henri Ducluzeau, Sonia Dulong, Vincent Durlach, Michel Farnier, Emile Ferrari, Dorota Ferrieres, Jean Ferrieres, Philippe Giral, Sophie Gonbert, Regis Hankard, Jocelyn Inamo, Olga Kalmykova, Michel Krempf, Julie Lemale, François Paillard, Noel Peretti, Agnes Perrin, Alain Pradignac, Jean Pierre Rabes, Vincent Rigalleau, François Schiele, Ariane Sultan, Patrick Tounian, René Valero, Bruno Verges, Cecile Yelnik, Olivier Ziegler, Rocío Aguado, Ma Pilar Álvarez-Baños, Rosa Argüeso, Francisco Arrieta, Miguel Ángel Barba, Marta Casañas, José María Cepeda, Raimundo De Andrés, Gonzalo Díaz-Soto, Jose Luis Díaz-Diaz, Marta Dieguez, Ceferino Faedo, Francisco Fuentes, Juan A. Garrido, Aurora González, Pablo González-Bustos, Ma Dolores Mañas, Marta Mauri, Juan Diego Mediavilla, Alfredo Michán, Pablo Miramontes, Ovidio Muñiz, Leire Pérez, Leopoldo Perez De Isla, Xavier Pintó, Manuel J. Romero, Patricia Rubio, Juan F. Sánchez Muñoz-Torrero, Jose I. Vidal-Pardo

Publikováno v: JACC: Cardiovascular Imaging
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2021, ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, 2021, 14 (12), pp.2414-2424. ⟨10.1016/j.jcmg.2021.06.011⟩

International audience; ObjectivesThis study aimed at investigating the additional contribution of coronary artery calcium (CAC) score to SAFEHEART (Spanish Familial Hypercholesterolemia Cohort Study) risk equation (SAFEHEART-RE) for cardiovascular r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792b88d656c760f4d97dfef1bcb93ecf
https://doi.org/10.1016/j.jcmg.2021.06.011

Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience

Autor: Patricia Rubio, Raimundo de Andrés, Raquel Arroyo-Olivares, Pedro Mata, María Dolores Mañas, Francisco Fuentes-Jiménez, Marta Casañas, Pilar Alvarez-Baños, Francisco Arrieta, Ovidio Muñiz-Grijalvo, Rodrigo Alonso, Leopoldo Pérez-Isla, José María Cepeda, Marta Dieguez, Juan Francisco Sánchez Muñoz-Torrero, José Luis Díaz-Díaz, Daniel Zambón, Pablo Gonzalez-Bustos, Rocío Aguado, Rosa Argüeso

Publikováno v: Journal of Clinical Lipidology. 15:584-592

PCSK9 inhibitors are a treatment option for patients with familial hypercholesterolemia not on low-density lipoprotein cholesterol goals despite the use of maximally tolerated high intensity-statins dose.To evaluate the efficacy of alirocumab and evo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e147af8624ec8d244793f7c628538c29
https://doi.org/10.1016/j.jacl.2021.04.011

Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry

Autor: Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Daniel Zambón, Francisco Fuentes, Nelva Mata, Mar Piedecausa, M. Dolores Mañas, Juan F. Sánchez Muñoz-Torrero, José Pablo Miramontes-González, Raimundo de Andrés, Marta Mauri, Rocío Aguado, Ángel Brea, José M. Cepeda, José I. Vidal-Pardo, Ceferino Martínez-Faedo, Miguel Ángel Barba, Rosa Argüeso, Enrique Ruiz-Pérez, Alfredo Michán, Francisco Arrieta, María Riestra Fernández, Leire Pérez, José M. Pinilla, Gonzalo Díaz-Soto, Xavier Pintó, Teresa Padró, Lina Badimón, Pedro Mata, Begoña Perez-Corral, Fátima Almagro, Raquel Arroyo, Adriana Saltijeral, Daniel Mosquera, Marta Casañas, Julio Carbayo, Jose María Cepeda, Raimundo De Andrés, José L. Díaz, Marta Diéguez, María Riestra, José López-Miranda, Jesús Galiana, Jesús García-Cruces, Juan Antonio Garrido, Luis Irigoyen, Pedro L. Martínez, Lorena Suárez, Rosa M. Borrallo, Juan Diego Mediavilla, Fernando Jaén, Pablo González, Patricia Rubio, Pablo Miramontes, Juan L. Morera, Ovidio Muñiz, Aurora González, Francisca Pereyra, José Pastor, José Miguel Pinilla, Manuel J. Romero, Enrique Ruiz, M. Pilar Álvarez, Pedro Sáenz, Juan F. Sánchez, Consuelo Sanz, Jose I. Vidal

Publikováno v: REVISTA ESPANOLA DE CARDIOLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)

Introduction and objectives: The SAFEHEART study was designed to analyze the situation of familial heterozygous hypercholesterolemia (FHH) and improve knowledge of this disease in Spain. Our objective was to determine the incidence rate of cardiovasc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed5a9a449d20bdfa7c0c0777222b214
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12027

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia

Autor: Leopoldo Perez de Isla, Rodrigo Alonso, Gerald F. Watts, Nelva Mata, Adriana Saltijeral Cerezo, Ovidio Muñiz, Francisco Fuentes, José Luís Diaz-Diaz, Raimundo de Andrés, Daniel Zambón, Patricia Rubio-Marin, Miguel A. Barba-Romero, Pedro Saenz, Juan F. Sanchez Muñoz-Torrero, Ceferino Martinez-Faedo, José P. Miramontes-Gonzalez, Lina Badimón, Pedro Mata, Rocío Aguado, Fátima Almagro, Francisco Arrieta, Miguel Ángel Barba, Ángel Brea, Jose María Cepeda, Raimundo De Andrés, Gonzalo Díaz, José L. Díaz, Jesús Galiana, Juan Antonio Garrido, Luis Irigoyen, Laura Manjón, Alberto Martin, Mar Piedecausa, Ceferino Martínez-Faedo, Marta Mauri, Pablo Miramontes, Francisca Pereyra, Leire Pérez, Xavier Pintó, Pedro Pujante, Enrique Ruiz, Pedro Sáenz, Juan F. Sánchez, Jose I. Vidal, Rosa Argüeso

Publikováno v: Journal of the American College of Cardiology. 67:1278-1285

Background Familial hypercholesterolemia (FH) is the most common genetic disorder associated with premature atherosclerotic cardiovascular disease (ASCVD). There are sparse data on attainment of treatment targets; large registries that reflect real-l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8d4509be00f79fd39a8ebd2e13d39ba
https://doi.org/10.1016/j.jacc.2016.01.008

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry

Autor: Leopoldo Pérez de Isla, Gonzalo Díaz-Soto, Adriana Saltijeral, Francisco Fuentes, José Luis Díaz-Díaz, Raimundo de Andrés, Pedro Mata, Lina Badimon, José Miguel Pinilla, Daniel Zambón, José Pastor, Nelva Mata, Xavier Pintó, Rodrigo Alonso, Ovidio Muñiz

Publikováno v: Revista Española de Cardiología (English Edition). 70:444-450

Introduction and objectives Little is known about the characteristics of persons with familial hypercholesterolemia (FH) younger than 18 years, the lipid-lowering therapy used in these patients, and the lipid goals reached in real life. Our aim was t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9cc3100e21fa28a021405e0528a67e
https://doi.org/10.1016/j.rec.2016.10.010